866-997-4948 (US-Canada Toll Free)

Global Markets Direct is a leading provider of global business intelligence and market analysis. The company publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. With a large dedicated research and analysis capability, Global Markets Direct employs...

Show More

Global Markets Direct is a leading provider of global business intelligence and market analysis. The company publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. With a large dedicated research and analysis capability, Global Markets Direct employs rigorous primary and secondary research techniques in developing unique data sets and research materials.

At the heart of Global Markets Direct are unique databases, updated live, covering millions of rows of key information for the studied industry at a global level.

Show Less
  • Dyskinesia - Pipeline Review, H1 2015

    Mar 2015

    By Global Markets Direct

    Pharmaceutical

    149 Pages

    Global Markets Direct’s, ‘Dyskinesia Pipeline Review, H1 2015’, provides an overview of the Dyskinesia’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Dyskinesia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of...

    USD 2000View Report
  • Pollen Allergy - Pipeline Review, H1 2015

    Mar 2015

    By Global Markets Direct

    Pharmaceutical

    103 Pages

    Global Markets Direct’s, ‘Pollen Allergy Pipeline Review, H1 2015’, provides an overview of the Pollen Allergy’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Pollen Allergy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route...

    USD 2000View Report
  • Uveitis - Pipeline Review, H1 2015

    Mar 2015

    By Global Markets Direct

    Pharmaceutical

    159 Pages

    Global Markets Direct’s, ‘Uveitis Pipeline Review, H1 2015’, provides an overview of the Uveitis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Uveitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration...

    USD 2000View Report
  • Fatty Liver Disease - Pipeline Review, H1 2015

    Mar 2015

    By Global Markets Direct

    Pharmaceutical

    123 Pages

    Global Markets Direct’s, ‘Fatty Liver Disease Pipeline Review, H1 2015’, provides an overview of the Fatty Liver Disease’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Fatty Liver Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of...

    USD 2000View Report
  • Bone Metastasis - Pipeline Review, H1 2015

    Mar 2015

    By Global Markets Direct

    Pharmaceutical

    107 Pages

    Global Markets Direct’s, ‘Bone Metastasis Pipeline Review, H1 2015’, provides an overview of the Bone Metastasis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Bone Metastasis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA),...

    USD 2000View Report
  • Cardiomyopathy - Pipeline Review, H1 2015

    Mar 2015

    By Global Markets Direct

    Pharmaceutical

    113 Pages

    Global Markets Direct’s, ‘Cardiomyopathy Pipeline Review, H1 2015’, provides an overview of the Cardiomyopathy’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Cardiomyopathy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route...

    USD 2000View Report
  • Tetanus - Pipeline Review, H1 2015

    Mar 2015

    By Global Markets Direct

    Pharmaceutical

    86 Pages

    Global Markets Direct’s, ‘Tetanus Pipeline Review, H1 2015’, provides an overview of the Tetanus’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Tetanus, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration...

    USD 2000View Report
  • Lysosomal Storage Disorder - Pipeline Review, H1 2015

    Mar 2015

    By Global Markets Direct

    Pharmaceutical

    105 Pages

    Global Markets Direct’s, ‘Lysosomal Storage Disorder Pipeline Review, H1 2015’, provides an overview of the Lysosomal Storage Disorder’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Lysosomal Storage Disorder, complete with comparative analysis at various stages, therapeutics assessment by drug...

    USD 2000View Report
  • Scar - Pipeline Review, H1 2015

    Mar 2015

    By Global Markets Direct

    Pharmaceutical

    104 Pages

    Global Markets Direct’s, ‘Scar Pipeline Review, H1 2015’, provides an overview of the Scar’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Scar, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and...

    USD 2000View Report
  • Fibrinogen Deficiency (Factor I Deficiency) - Pipeline Review, H1 2015

    Mar 2015

    By Global Markets Direct

    Pharmaceutical

    38 Pages

    Global Markets Direct’s, ‘Fibrinogen Deficiency (Factor I Deficiency) Pipeline Review, H1 2015’, provides an overview of the Fibrinogen Deficiency (Factor I Deficiency)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Fibrinogen Deficiency (Factor I Deficiency), complete with comparative analysis at...

    USD 2000View Report
  • Meniere Disease - Pipeline Review, H1 2015

    Mar 2015

    By Global Markets Direct

    Pharmaceutical

    43 Pages

    Global Markets Direct’s, ‘Meniere Disease Pipeline Review, H1 2015’, provides an overview of the Meniere Disease’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Meniere Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA),...

    USD 2000View Report
  • Becker Muscular Dystrophy - Pipeline Review, H1 2015

    Mar 2015

    By Global Markets Direct

    Pharmaceutical

    39 Pages

    Global Markets Direct’s, ‘Becker Muscular Dystrophy Pipeline Review, H1 2015’, provides an overview of the Becker Muscular Dystrophy’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Becker Muscular Dystrophy, complete with comparative analysis at various stages, therapeutics assessment by drug target,...

    USD 2000View Report
  • Corneal Graft Rejection - Pipeline Review, H1 2015

    Mar 2015

    By Global Markets Direct

    Pharmaceutical

    39 Pages

    Global Markets Direct’s, ‘Corneal Graft Rejection Pipeline Review, H1 2015’, provides an overview of the Corneal Graft Rejection’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Corneal Graft Rejection, complete with comparative analysis at various stages, therapeutics assessment by drug target,...

    USD 2000View Report
  • Pneumocystis Infection - Pipeline Review, H1 2015

    Mar 2015

    By Global Markets Direct

    Pharmaceutical

    29 Pages

    Global Markets Direct’s, ‘Pneumocystis Infection Pipeline Review, H1 2015’, provides an overview of the Pneumocystis Infection’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Pneumocystis Infection, complete with comparative analysis at various stages, therapeutics assessment by drug target,...

    USD 2000View Report
  • Aeolus Pharmaceuticals, Inc. - Product Pipeline Review - 2015

    Mar 2015

    By Global Markets Direct

    Pharmaceutical

    36 Pages

    Global Markets Direct’s, ‘Aeolus Pharmaceuticals, Inc. Product Pipeline Review 2015’, provides an overview of the Aeolus Pharmaceuticals, Inc.’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Aeolus Pharmaceuticals, Inc.’s, complete with comparative...

    USD 1500View Report
  • Bio3 Research S.r.l - Product Pipeline Review - 2015

    Mar 2015

    By Global Markets Direct

    Pharmaceutical

    24 Pages

    Global Markets Direct’s, ‘Bio3 Research S.r.l Product Pipeline Review 2015’, provides an overview of the Bio3 Research S.r.l’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Bio3 Research S.r.l’s, complete with comparative analysis at various stages,...

    USD 1500View Report
  • USV Limited - Product Pipeline Review - 2015

    Mar 2015

    By Global Markets Direct

    Pharmaceutical

    29 Pages

    Global Markets Direct’s, ‘USV Limited Product Pipeline Review 2015’, provides an overview of the USV Limited’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of USV Limited’s, complete with comparative analysis at various stages, therapeutics assessment by...

    USD 1500View Report
  • Orphazyme ApS - Product Pipeline Review - 2015

    Mar 2015

    By Global Markets Direct

    Pharmaceutical

    25 Pages

    Global Markets Direct’s, ‘Orphazyme ApS Product Pipeline Review 2015’, provides an overview of the Orphazyme ApS’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Orphazyme ApS’s, complete with comparative analysis at various stages, therapeutics...

    USD 1500View Report
  • Acacia Pharma Ltd. - Product Pipeline Review - 2015

    Mar 2015

    By Global Markets Direct

    Pharmaceutical

    27 Pages

    Global Markets Direct’s, ‘Acacia Pharma Ltd. Product Pipeline Review 2015’, provides an overview of the Acacia Pharma Ltd.’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Acacia Pharma Ltd.’s, complete with comparative analysis at various stages,...

    USD 1500View Report
  • Acumen Pharmaceuticals, Inc. - Product Pipeline Review - 2015

    Mar 2015

    By Global Markets Direct

    Pharmaceutical

    22 Pages

    Global Markets Direct’s, ‘Acumen Pharmaceuticals, Inc. Product Pipeline Review 2015’, provides an overview of the Acumen Pharmaceuticals, Inc.’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Acumen Pharmaceuticals, Inc.’s, complete with comparative...

    USD 1500View Report
  • Acucela Inc. - Product Pipeline Review - 2015

    Mar 2015

    By Global Markets Direct

    Pharmaceutical

    27 Pages

    Global Markets Direct’s, ‘Acucela Inc. Product Pipeline Review 2015’, provides an overview of the Acucela Inc.’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Acucela Inc.’s, complete with comparative analysis at various stages, therapeutics assessment...

    USD 1500View Report
  • Nabriva Therapeutics AG - Product Pipeline Review - 2015

    Mar 2015

    By Global Markets Direct

    Pharmaceutical

    26 Pages

    Global Markets Direct’s, ‘Nabriva Therapeutics AG Product Pipeline Review 2015’, provides an overview of the Nabriva Therapeutics AG’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Nabriva Therapeutics AG’s, complete with comparative analysis at...

    USD 1500View Report
  • Circadian Technologies Limited - Product Pipeline Review - 2015

    Mar 2015

    By Global Markets Direct

    Pharmaceutical

    28 Pages

    Global Markets Direct’s, ‘Circadian Technologies Limited Product Pipeline Review 2015’, provides an overview of the Circadian Technologies Limited’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Circadian Technologies Limited’s, complete with...

    USD 1500View Report
  • Human Papillomavirus Infections - Pipeline Review, H1 2015

    Mar 2015

    By Global Markets Direct

    Pharmaceutical

    144 Pages

    Global Markets Direct’s, ‘Human Papillomavirus Infections Pipeline Review, H1 2015’, provides an overview of the Human Papillomavirus Infections’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Human Papillomavirus Infections, complete with comparative analysis at various stages, therapeutics...

    USD 2000View Report
  • Herpes Simplex Infections - Pipeline Review, H1 2015

    Mar 2015

    By Global Markets Direct

    Pharmaceutical

    188 Pages

    Global Markets Direct’s, ‘Herpes Simplex Infections Pipeline Review, H1 2015’, provides an overview of the Herpes Simplex Infections’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Herpes Simplex Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target,...

    USD 2000View Report